Breast cancer statistics, 2017, racial disparity in mortality by state

CA Cancer Journal for Clinicians

Volumn 67, Issue 6, 2017, Pages 439-448

  DeSantis, Carol E ^a   Ma, Jiemin ^a   Goding Sauer, Ann ^a   Newman, Lisa A ^b   Jemal, Ahmedin ^a  

^a AMERICAN CANCER SOCIETY   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

breast neoplasms; epidemiology; health disparities

Indexed keywords

ADULT; AGED; AMERICAN INDIAN; ARTICLE; BLACK PERSON; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; CAUCASIAN; ETHNIC DIFFERENCE; FEMALE; GEOGRAPHIC DISTRIBUTION; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MORTALITY RATE; PACIFIC ISLANDER; PRIORITY JOURNAL; RACE DIFFERENCE; UNITED STATES; WOMEN'S HEALTH; BREAST TUMOR; EARLY CANCER DIAGNOSIS; EPIDEMIOLOGY; ETHNOLOGY; INCIDENCE; MASS SCREENING; MORTALITY; NON PROFIT ORGANIZATION; SURVIVAL RATE;

ADULT; AGED; AMERICAN CANCER SOCIETY; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; MASS SCREENING; SURVIVAL RATE; UNITED STATES;

EID: 85033213848     PISSN: 00079235     EISSN: 15424863     Source Type: Journal    
DOI: 10.3322/caac.21412     Document Type: Article

References (44)

1. Surveillance, Epidemiology, and End Results (SEER) Program (seer.cancer.gov) SEER*Stat Database: Incidence - SEER 9 Regs Research Data, Nov 2016 Sub (1973-2014) < Katrina/Rita Population Adjustment > Total U.S., 1969-2015 Counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program; released April 2017, based on the November 2016 submission.
2. Surveillance, Epidemiology, and End Results (SEER) Program (seer.cancer.gov) SEER*Stat Database: Incidence - SEER 13 Regs Research Data with Delay-Adjustment, Malignant Only, Nov 2016 Sub (1992-2014) < Katrina/Rita Population Adjustment > - Linked To County Attributes - Total U.S., 1969-2015 Counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program; released April 2017, based on the November 2016 submission.
3. Surveillance, Epidemiology, and End Results (SEER) Program (seer.cancer.gov) SEER*Stat Database: Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2016 Sub (2000-2014) < Katrina/Rita Population Adjustment > - Linked To County Attributes - Total U.S., 1969-2015 Counties Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program; released April 2017, based on the November 2016 submission.
4. Surveillance, Epidemiology, and End Results (SEER) Program (seer.cancer.gov). SEER*Stat Database: North American Association of Central Cancer Registries(NAACCR) Incidence Data - Cancer in North America (CiNA) Analytic File, 1995-2014, for NHIAv2 Origin. Custom File With County, ACS Facts and Figures Projection Project (which includes data from the CDC National Program of Cancer Registries [NPCR], the Canadian Cancer Registry (CCR) Provincial and Territorial Registries, and the NCI SEER Registries), certified by the NAACCR as meeting high-quality incidence data standards for the specified time periods. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program; submitted December 2016.
5. Copeland G, Lake A, Firth R, et al. Cancer in North America: 2010-2014. Volume 2: Registry-Specific Cancer Incidence for the United States, Canada and North America. Springfield, IL: North American Association of Central Cancer Registries, Inc; 2017.
6. Surveillance, Epidemiology, and End Results (SEER) Program (seer.cancer.gov). SEER*Stat Database: Mortality-All COD, Total U.S. (1969-2015) < Early Release with Vintage 2015 Katrina/Rita Population Adjustment > - Linked To County Attributes - Total U.S., 1969-2015 Counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program; released June 2017. Underlying mortality data provided by NCHS (cdc.gov/nchs).
7. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data. Atlanta, GA: US Department of Health and Human Services, CDC; 2017.
8. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7-30.
9. Anderson WF, Katki HA, Rosenberg PS. Incidence of breast cancer in the United States: current and future trends. J Natl Cancer Inst. 2011;103:1397-1402.
10. Surveillance Research Program, National Cancer Institute. SEER*Stat Software. Version 8.3.4. Bethesda, MD: National Cancer Institute; 2017.
11. Surveillance Research Program. Joinpoint Regression Program, Version 4.5.0.1. Bethesda, MD: Statistical Research and Applications Branch, National Cancer Institute; 2017.
12. Surveillance Research Program. DevCan: Probability of Developing or Dying of Cancer Software, Version 6.7.5. Bethesda, MD: Statistical Research and Applications Branch, National Cancer Institute; 2017.
13. Howlader N, Noone AM, Krapcho M, et al. eds. SEER Cancer Statistics Review, 1975-2014. (seer.cancer.gov/csr/1975_2014/), based on November 2016 SEER data submission, posted to the SEER web site, April 2017. Bethesda, MD: National Cancer Institute; 2017.
14. Anderson WF, Rosenberg PS, Prat A, Perou CM, Sherman ME. How many etiological subtypes of breast cancer: two, three, four, or more? J Natl Cancer Inst. 2014;106:dju165.
15. Barnard ME, Boeke CE, Tamimi RM. Established breast cancer risk factors and risk of intrinsic tumor subtypes. Biochim Biophys Acta. 2015;1856:73-85.
16. Cheang MC, Martin M, Nielsen TO, et al. Defining breast cancer intrinsic subtypes by quantitative receptor expression. Oncologist. 2015;20:474–482.
17. Parise C, Caggiano V. Disparities in the risk of the ER/PR/HER2 breast cancer subtypes among Asian Americans in California. Cancer Epidemiol. 2014;38:556-562.
18. Ma H, Ursin G, Xu X, et al. Reproductive factors and the risk of triple-negative breast cancer in white women and African-American women: a pooled analysis [serial online]. Breast Cancer Res. 2017;19:6.
19. Hines LM, Sedjo RL, Byers T, et al. The interaction between genetic ancestry and breast cancer risk factors among Hispanic women: the Breast Cancer Health Disparities Study. Cancer Epidemiol Biomarkers Prev. 2017;26:692-701.
20. Huo D, Hu H, Rhie SK, et al. Comparison of breast cancer molecular features and survival by African and European ancestry in The Cancer Genome Atlas [published online ahead of print May 4, 2017]. JAMA Oncol. doi: 10.1001/jamaoncol.2017.0595.
21. Newman LA, Kaljee LM. Health disparities and triple-negative breast cancer in African American women: a review. JAMA Surg. 2017;152:485-493.
22. Sullivan PD, Christine B, Connelly R, Barrett H. Analysis of trends in age-adjusted incidence rates for 10 major sites of cancer. Am J Public Health. 1972;62:1065-1071.
23. Devesa SS, Silverman DT, Young JL Jr, et al. Cancer incidence and mortality trends among whites in the United States, 1947-84. J Natl Cancer Inst. 1987;79:701-770.
24. Toriola AT, Colditz GA. Trends in breast cancer incidence and mortality in the United States: implications for prevention. Breast Cancer Res Treat. 2013;138:665-673.
25. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.
26. Ravdin PM, Cronin KA, Howlader N, et al. The decrease in breast cancer incidence in 2003 in the United States. N Engl J Med. 2007;356:1670-1674.
27. Coombs NJ, Cronin KA, Taylor RJ, Freedman AN, Boyages J. The impact of changes in hormone therapy on breast cancer incidence in the US population. Cancer Causes Control. 2010;21:83-90.
28. DeSantis C, Howlader N, Cronin KA, Jemal A. Breast cancer incidence rates in US women are no longer declining. Cancer Epidemiol Biomarkers Prev. 2011;20:733-739.
29. National Center for Health Statistics. Health, United States, 2016: With Chartbook on Long-Term Trends in Health. Hyattsville, MD: National Center for Health Statistics; 2017.
30. Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353:1784-1792.
31. Munoz D, Near AM, van Ravesteyn NT, et al. Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality [serial online]. J Natl Cancer Inst. 2014;106:dju289.
32. Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66:271-289.
33. Elkin EB, Hudis C, Begg CB, Schrag D. The effect of changes in tumor size on breast carcinoma survival in the United States: 1975-1999. Cancer. 2005;104:1149-1157.
34. Park JH, Anderson WF, Gail MH. Improvements in US breast cancer survival and proportion explained by tumor size and estrogen-receptor status. J Clin Oncol. 2015;33:2870-2876.
35. Daly B, Olopade OI. A perfect storm: how tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change. CA Cancer J Clin. 2015;65:221-238.
36. Kaplan HG, Malmgren JA. Impact of triple negative phenotype on breast cancer prognosis. Breast J. 2008;14:456-463.
37. Iqbal J, Ginsburg O, Rochon PA, Sun P, Narod SA. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. JAMA. 2015;313:165-173.
38. Warner ET, Tamimi RM, Hughes ME, et al. Racial and ethnic differences in breast cancer survival: mediating effect of tumor characteristics and sociodemographic and treatment factors. J Clin Oncol. 2015;33:2254-2261.
39. Tao L, Gomez SL, Keegan TH, Kurian AW, Clarke CA. Breast cancer mortality in African-American and non-Hispanic white women by molecular subtype and stage at diagnosis: a population-based study. Cancer Epidemiol Biomarkers Prev. 2015;24:1039-1045.
40. Sighoko D, Murphy AM, Irizarry B, Rauscher G, Ferrans C, Ansell D. Changes in the racial disparity in breast cancer mortality in the ten US cities with the largest African American populations from 1999 to 2013: the reduction in breast cancer mortality disparity in Chicago. Cancer Causes Control. 2017;28:563-568.
41. Hunt BR, Hurlbert MS. Black:white disparities in breast cancer mortality in the 50 largest cities in the United States, 2005-2014. Cancer Epidemiol. 2016;45:169-173.
42. Rust G, Zhang S, Malhotra K, et al. Paths to health equity: local area variation in progress toward eliminating breast cancer mortality disparities, 1990-2009. Cancer. 2015;121:2765-2774.
43. Van Der Wees PJ, Zaslavsky AM, Ayanian JZ. Improvements in health status after Massachusetts health care reform. Milbank Q. 2013;91:663-689.
44. Grubbs SS, Polite BN, Carney J Jr, et al. Eliminating racial disparities in colorectal cancer in the real world: it took a village. J Clin Oncol. 2013;31:1928-1930.